TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Operating Expenses (2020 - 2026)

Updated

TScan Therapeutics (TCRX) reported Operating Expenses of $33.62 million for Q3 2026, down 15.0% from $39.56 million a year earlier but up 6.6% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Operating Expenses (2020 - 2026) Analysis & Trends

Over the twelve months ended Sep 30, 2026, TScan Therapeutics' Operating Expenses came in at $121.71 million, down 22.5% year-over-year; for FY2025, it came in at $146.14 million, up 6.2% from FY2024.

  • Operating Expenses has increased for five consecutive years, with a five-year compound annual growth rate of 39.9% (FY2020 to FY2025).
  • By year, Operating Expenses came in at $137.64 million in FY2024 (+20.2%), $114.51 million in FY2023 (+42.8%), $80.17 million in FY2022 (+36.4%) and $58.78 million in FY2021 (+115.2%).
  • Five-year quarterly Operating Expenses spans a low of $17.06 million in Q4 2021 and a high of $41.73 million in Q2 2025.
  • Year over year, Operating Expenses has now declined in each of the last four quarters, with an average decline of 0.2% over the last eight quarters.
  • The high point for year-over-year Operating Expenses in five years was Q4 2021 (growth of 98.2%); the low point was Q4 2025 (a decline of 29.3%).
  • Per Business Quant data, the three quarters before Q3 2026 came in at $31.54 million (Q2 2026), $30.12 million (Q1 2026) and $26.43 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 2.13 Mn
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 15.99 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 11.12 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 11.14 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 12.53 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 6.66 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 4.84 Bn
9 Gsk 193.54 Bn 176.38 Bn - -
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 33.62 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 33.62 Mn
Jun 30, 2026 31.54 Mn
Mar 31, 2026 30.12 Mn
Dec 31, 2025 26.43 Mn
Sep 30, 2025 39.56 Mn
Jun 30, 2025 41.73 Mn
Mar 31, 2025 38.42 Mn
Dec 31, 2024 37.38 Mn
Sep 30, 2024 33.67 Mn
Jun 30, 2024 34.65 Mn
Mar 31, 2024 31.94 Mn
Dec 31, 2023 28.57 Mn
Sep 30, 2023 28.64 Mn
Jun 30, 2023 27.76 Mn
Mar 31, 2023 29.55 Mn
Dec 31, 2022 21.74 Mn
Sep 30, 2022 19.94 Mn
Jun 30, 2022 19.30 Mn
Mar 31, 2022 19.18 Mn
Dec 31, 2021 17.06 Mn
API Access

TScan Therapeutics Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=TCRX&period=max&api_key=YOUR_API_KEY